Pictet Asset Management (Switzerland)’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$67.7M Buy
3,575,126
+2,598,575
+266% +$45.6M 0.08% 250
2023
Q1
$14.9M Buy
+976,551
New +$12.7M 0.02% 536

Other funds holding ETNB

Pictet Asset Management (Switzerland)'s ETNB Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its 89bio (ETNB) stake by 266% in Q2 2023, buying an estimated $45.6M and bringing the position to 3,575,126 shares worth $67.7M. The position accounts for 0.08% of the portfolio, ranked #250.

Pictet Asset Management (Switzerland) first reported a position in ETNB in Q1 2023 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 3,575,126 shares of 89bio worth $67.7M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 2,598,575 89bio shares in Q2 2023, an estimated $45.6M.
  • 89bio made up 0.08% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #250 holding.
  • Pictet Asset Management (Switzerland) first reported a position in 89bio in Q1 2023 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.